Isaac Francis

Syrah Resources (ASX:SYR) has signed multi-year binding conditional offtake agreement with NextSource Materials.

Pharvaris (NASDAQ:PHVS) dominated the clinical spotlight at the American Academy of Allergy, Asthma & Immunology (AAAAI) 2026 meeting on Monday, unveiling full data from its RAPIDe-3 and CHAPTER-1 trials.

Cardano’s native token ADA is changing hands near $0.27, a steep fall from its September 2021 all-time high of $3.10, marking a decline of roughly 90%.

Strategy Inc. has purchased an additional 3,015 bitcoin for around $204.1 million, further expanding its already dominant corporate position in the crypto market.

Apogee Therapeutics (NASDAQ:APGE) solidified its clinical roadmap for 2026 on Monday, reporting a year-end cash position of $902.9 million.

uniQure (NASDAQ:QURE) entered 2026 with a dual narrative of clinical progress and regulatory complexity.

EchoStar (NASDAQ:SATS) disclosed a massive $14.50 billion net loss for the full year 2025, a figure primarily fueled by a series of aggressive accounting adjustments to its balance sheet.

RadNet (NASDAQ:RDNT) announced a definitive agreement on Monday to acquire Gleamer SAS, a Paris-based pioneer in radiology artificial intelligence, for a total consideration of up to €230 million.

Global equity markets retreated sharply on Monday as a coordinated U.S. and Israeli military strike against Iran upended geopolitical stability, sending shockwaves through the travel and discretionary sectors.

Kosmos Energy (NYSE:KOS) reported a fourth-quarter net loss of $377 million, or $0.79 per share, as the company prioritized balance sheet discipline and portfolio optimization at the close of 2025.